|
Volumn 26, Issue 2, 2005, Pages 359-361
|
New intralesional therapy for basal cell carcinoma by 2% zinc sulphate solution
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALCOHOL;
LIDOCAINE;
ZINC SULFATE;
ADULT;
AGED;
ARTICLE;
BASAL CELL CARCINOMA;
BASAL CELL NEVUS SYNDROME;
CANCER LOCALIZATION;
CANCER RELAPSE;
CLINICAL ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
MALE;
MINIMAL RESIDUAL DISEASE;
PAIN;
PRURITUS;
SKIN BIOPSY;
SYMPTOMATOLOGY;
SYSTEMIC DISEASE;
TUMOR VOLUME;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, BASAL CELL;
FEMALE;
HUMANS;
INJECTIONS, INTRALESIONAL;
MALE;
MIDDLE AGED;
SKIN NEOPLASMS;
TREATMENT OUTCOME;
ZINC SULFATE;
|
EID: 17144408330
PISSN: 03795284
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (5)
|